^
Association details:
| Biomarker: | NTRK2 fusion |
|---|---|
| Cancer: | Thyroid Gland Anaplastic Carcinoma |
| Drug: | Rozlytrek (entrectinib) (ALK inhibitor, TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor, ROS1 inhibitor, JAK2 inhibitor, TNK2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
…larotrectinib or enterectinib if NTRK gene fusion positive…
